Melatonin |
|
 |
|
Melatonin, also known chemically as N-acetyl-5-methoxytryptamine, is a naturally occurring hormone found in animals and in some other living organisms, including algae. Circulating levels vary in a daily cycle, and melatonin is important in the regulation of the circadian rhythms of several biological functions. Many biological effects of melatonin are produced through activation of melatonin receptors,[4] while others are due to its role as a pervasive and powerful antioxidant[5] with a particular role in the protection of nuclear and mitochondrial DNA.
Products containing melatonin have been available as a dietary supplement in the United States since 1993. Foods may contain trace amounts of melatonin, but no food has been found to elevate plasma melatonin levels.[8] Over-the-counter sales of the hormone remain illegal in many other countries, and the U.S. Postal Service lists melatonin among items prohibited by Germany.
| Dosage |
Packing |
Price |
Add to basket |
| 2 mg |
21 tab |
USD 39.00 |
 |
Melatonin generic (generic - what is it?)
| Dosage |
Packing |
Price |
Add to basket |
| 3 mg |
100 tab |
USD 34.00 |
|
Melatonin: Medications and Prescriptions
Generic name: melatonin
Product Brand Name: Circadin
Melatonin description
Biosynthesis:
In higher animals, including humans, melatonin is produced by pinealocytes in the pineal gland (located in the brain, but outside of the blood-brain barrier) and also by the retina, lens, GI tract and other tissues. The largest organ in humans to biosynthesize melatonin is the skin. All machinery for melatonin synthesis has been identified in skin cells and both melatonin and its byproduct, AFMK, have been found. Both of these molecules are naturally synthesized from the amino acid tryptophan (via synthesis of serotonin). Serotonin is converted to melatonin by the enzymes N-acetyltransferase and 5-hydroxyindole-O-methyltransferase.
Production of melatonin by the pineal gland is under the influence of the suprachiasmatic nuclei (SCN) of the hypothalamus, which receive information from the retina about the daily pattern of light and darkness. Both SCN rhythmicity and melatonin production are affected by non-image-forming light information traveling through the recently-identified retinohypothalamic tract (RHT).
The light/dark information reaches the SCN via retinal photosensitive ganglion cells, intrinsically photosensitive photoreceptor cells, distinct from those involved in image forming (that is, these light sensitive cells are a third type in the retina, in addition to rods and cones). These cells represent approximately 2% of the retinal ganglion cells in humans and express the photopigment melanopsin.[10] The sensitivity of melanopsin fits with that of a vitamin A-based photopigment with a peak sensitivity at 484 nm (blue light). This photoperiod cue entrains the circadian rhythm, and the resultant production of specific "dark"- and "light"-induced neural and endocrine signals which regulate behavioral and physiological circadian rhythms.
Melatonin may also be produced by a variety of peripheral cells such as bone marrow cells, lymphocytes and epithelial cells. Usually, the melatonin concentration in these cells is much higher than that found in the blood but it does not seem to be regulated by the photoperiod.
Melatonin is also synthesized by various plants, such as rice, and ingested melatonin has been shown to be capable of reaching and binding to melatonin binding sites in the brains of mammals.
History:
Melatonin is related to the mechanism by which some amphibians and reptiles change the color of their skin and, indeed, it was in this connection the substance first was discovered. McCord and Allen discovered (J Exptl Zool, 1917) that extract of the pineal glands of cows lightened frog skin, while Aaron B. Lerner is credited for naming the hormone and for defining its chemical structure in 1958. In the mid-70s Lynch et al. demonstrated that also in humans the production of melatonin exhibits a circadian rhythm.
Distribution in the mammalian body:
Melatonin produced in the pineal gland, which is outside of the blood-brain barrier, acts as an endocrine hormone since it is released into the blood. By contrast, melatonin produced by the retina and the gastrointestinal (GI) tract acts as a paracrine hormone.
Roles in non-human animals:
Many animals use the variation in duration of melatonin production each day as a seasonal clock. In animals and humans the profile of melatonin synthesis and secretion is affected by the variable duration of night in summer as compared to winter. The change in duration of secretion thus serves as a biological signal for the organisation of daylength-dependent (photoperiodic) seasonal functions such as reproduction, behaviour, coat growth and camouflage colouring in seasonal animals. In seasonal breeders which do not have long gestation periods and which mate during longer daylight hours, the melatonin signal controls the seasonal variation in their sexual physiology, and similar physiological effects can be induced by exogenous melatonin in animals including mynah birds and hamsters. Melatonin can suppress libido by inhibiting secretion of luteinizing hormone (LH) and follicle stimulating hormone (FSH) from the anterior pituitary gland, especially in mammals that have a breeding season when daylight hours are long. The reproduction of long-day breeders is repressed by melatonin and the reproduction of short-day breeders is stimulated by melatonin.
During the night, melatonin regulates leptin, lowering the levels; see Leptin.
Roles in humans:
Circadian rhythm
In humans, melatonin is produced by the pineal gland, a gland about the size of a pea, located in the center of the brain but outside of the blood-brain barrier. The melatonin signal forms part of the system that regulates the sleep-wake cycle by chemically causing drowsiness and lowering the body temperature, but it is the central nervous system (more specifically, the suprachiasmatic nuclei, SCN) that controls the daily cycle in most components of the paracrine and endocrine systems rather than the melatonin signal (as was once postulated).
Light dependence:
Production of melatonin by the pineal gland is inhibited by light and permitted by darkness. For this reason melatonin has been called "the hormone of darkness" and its onset each evening is called the Dim-Light Melatonin Onset (DLMO). Secretion of melatonin as well as its level in the blood, peaks in the middle of the night, and gradually falls during the second half of the night, with normal variations in timing according to an individual's chronotype.
Until recent history, humans in temperate climates were exposed to only about six hours of daylight in the winter. In the modern world, artificial lighting reduces darkness exposure to typically eight or fewer hours per day all year round. Even low light levels inhibit melatonin production to some extent, but over-illumination can create significant reduction in melatonin production. Since it is principally blue light that suppresses melatonin,[25] wearing glasses that block blue light in the hours before bedtime may avoid melatonin loss. Use of blue-blocking goggles the last hours before bedtime has also been advised for people who need to adjust to an earlier bedtime, as melatonin promotes sleepiness.
Antioxidant:
Besides its function as synchronizer of the biological clock, melatonin also exerts a powerful antioxidant activity. The discovery of melatonin as an antioxidant was made in 1993. In many lower life forms, it serves only this purpose. Melatonin is an antioxidant that can easily cross cell membranes and the blood-brain barrier. Melatonin is a direct scavenger of OH, O2−, and NO. Unlike other antioxidants, melatonin does not undergo redox cycling, the ability of a molecule to undergo reduction and oxidation repeatedly. Redox cycling may allow other antioxidants (such as vitamin C) to regain their antioxidant properties. Melatonin, on the other hand, once oxidized, cannot be reduced to its former state because it forms several stable end-products upon reacting with free radicals. Therefore, it has been referred to as a terminal (or suicidal) antioxidant.
Recent research indicates that the first metabolite of melatonin in the melatonin antioxidant pathway may be N(1)-acetyl-N(2)-formyl-5-methoxykynuramine (or AFMK) rather than the common, excreted 6-hydroxymelatonin sulfate. AFMK alone is detectable in unicellular organisms and metazoans. A single AFMK molecule can neutralize up to 10 ROS/RNS (reactive oxygen species/reactive nitrogen species) since many of the products of the reaction/derivatives (including melatonin) are themselves antioxidants. This capacity to absorb free radicals extends at least to the quaternary metabolites of melatonin, a process referred to as "the free radical scavenging cascade". This is not true of other, conventional antioxidants.
In animal models, melatonin has been demonstrated to prevent the damage to DNA by some carcinogens, stopping the mechanism by which they cause cancer. It also has been found to be effective in protecting against brain injury caused by ROS release in experimental hypoxic brain damage in newborn rats. Melatonin's antioxidant activity may reduce damage caused by some types of Parkinson's disease, may play a role in preventing cardiac arrhythmia and may increase longevity; it has been shown to increase the average life span of mice by 20% in some studies.
Immune system:
While it is known that melatonin interacts with the immune system, the details of those interactions are unclear. There have been few trials designed to judge the effectiveness of melatonin in disease treatment. Most existing data are based on small, incomplete clinical trials. Any positive immunological effect is thought to result from melatonin acting on high affinity receptors (MT1 and MT2) expressed in immunocompetent cells. In preclinical studies, melatonin may enhance cytokine production,[38] and by doing this counteract acquired immunodeficiences. Some studies also suggest that melatonin might be useful fighting infectious disease including viral, such as HIV, and bacterial infections, and potentially in the treatment of cancer.
Endogenous melatonin in human lymphocytes has been related to interleukin-2 (IL-2) production and to the expression of IL-2 receptor. This suggests that melatonin is involved in the clonal expansion of antigen-stimulated human T lymphocytes. When taken in conjunction with calcium, it is an immunostimulator[citation needed] and is used as an adjuvant in some clinical protocols[citation needed]; conversely, the increased immune system activity may aggravate autoimmune disorders. In rheumatoid arthritis patients, melatonin production has been found increased when compared to age-matched healthy controls.
Dreaming:
Some supplemental melatonin users report an increase in vivid dreaming. Extremely high doses of melatonin (50 mg) dramatically increased REM sleep time and dream activity in both people with and people without narcolepsy. Many psychoactive drugs, such as cannabis and lysergic acid diethylamide (LSD), increase melatonin synthesis. It has been suggested that nonpolar (lipid-soluble) indolic hallucinogenic drugs emulate melatonin activity in the awakened state and that both act on the same areas of the brain.[43]
Autism:
Individuals with autism spectrum disorders (ASD) may have lower than normal levels of melatonin. A 2008 study found that unaffected parents of individuals with ASD also have lower melatonin levels, and that the deficits were associated with low activity of the ASMT gene, which encodes the last enzyme of melatonin synthesis.
Current and potential medical indications:
Melatonin has been studied for the treatment of cancer, immune disorders, cardiovascular diseases, depression, seasonal affective disorder (SAD), circadian rhythm sleep disorders and sexual dysfunction. Studies by Alfred J. Lewy at Oregon Health & Science University and other researchers have found that it may ameliorate circadian misalignment and SAD. Basic research indicates that melatonin may play a significant role in modulating the effects of drugs of abuse such as cocaine.
Treatment of circadian rhythm disorders:
Exogenous melatonin taken in the evening is, together with light therapy upon awakening, the standard treatment for delayed sleep phase syndrome and non-24-hour sleep-wake syndrome. It appears to have some use against other circadian rhythm sleep disorders as well, such as jet lag and the problems of people who work rotating or night shifts.
Taken 30 to 90 minutes before bedtime, melatonin supplementation acts as a mild hypnotic. It causes melatonin levels in the blood to rise earlier than the brain's own production accomplishes.
A very small dose taken several hours before bedtime in accordance with the phase response curve for melatonin in humans (PRC) doesn't cause sleepiness but, acting as a chronobiotic (affecting aspects of biological time structure), advances the phase slightly and is additive to the effect of using light therapy upon awakening. Light therapy may advance the phase about one to two-and-a-half hours and a small oral dose melatonin, timed correctly some hours before bedtime, can add about 30 minutes to the advance achieved with light therapy.
Preventing ischemic damage:
Melatonin has been shown to reduce tissue damage in rats due to ischemia in both the brain and the heart; however, this has not been tested in humans.
Learning, memory and Alzheimer's:
Melatonin receptors appear to be important in mechanisms of learning and memory in mice, and melatonin can alter electrophysiological processes associated with memory, such as long-term potentiation (LTP). The first published evidence that melatonin may be useful in Alzheimer's disease was the demonstration that this neurohormone prevents neuronal death caused by exposure to the amyloid beta protein, a neurotoxic substance that accumulates in the brains of patients with the disorder. Melatonin also inhibits the aggregation of the amyloid beta protein into neurotoxic microaggregates which seem to underlie the neurotoxicity of this protein, causing death of neurons and formation of neurofibrillary tangles, the other neuropathological landmark of Alzheimer's disease.
Melatonin has been shown to prevent the hyperphosphorylation of the tau protein in rats. Hyperphosphorylation of tau protein can also result in the formation of neurofibrillary tangles. Studies in rats suggest that melatonin may be effective for treating Alzheimer's disease.[53] These same neurofibrillary tangles can be found in the hypothalamus in patients with Alzheimer's, adversely affecting their bodies' production of melatonin. Those Alzheimer's patients with this specific affliction often show heightened afternoon agitation, called sundowning, which has been shown in many studies to be effectively treated with melatonin supplements in the evening.
ADHD:
Research shows that after melatonin is administered to ADHD patients on methylphenidate, the time needed to fall asleep is significantly reduced. Furthermore, the effects of the melatonin after three months showed no change from its effects after one week of use.
Fertility:
A research team in Italy has found that melatonin supplementation in the evening in perimenopausal women produces an improvement in thyroid function and gonadotropin levels, as well as restoring fertility and menstruation and preventing the depression associated with the menopause. However, at the same time, some resources warn women trying to conceive not to take a melatonin supplement. One study reported that three mg of melatonin taken in the evening raised prolactin levels in six out of seven women. Melatonin also lowers FSH levels. It is believed that these hormonal changes could in some women impair fertility.
Toxicology:
Melatonin has a very low toxicity in rats. Rat maternal toxicity: the no observable adverse effect level (NOAEL) and lowest observed adverse effect level (LOAEL) were 100 and 200 mg/kg/day, respectively, and the developmental toxicity NOAEL was >= 200 mg/kg/day.
Headaches:
Several clinical studies indicate that supplementation with melatonin is an effective preventive treatment for migraines and cluster headaches.
Mood disorders:
Melatonin has been shown to be effective in treating one form of depression, seasonal affective disorder, and is being considered for bipolar and other disorders where circadian disturbances are involved.[62] It has been observed that bipolar disorder might have, as a "trait marker" (something which is characteristic of being bipolar, that doesn't change with state), supersensitivity to light, i.e. a greater decrease in melatonin secretion in response to light exposure at night.[63] This could be contrasted with drug-free recovered bipolar people not showing light hypersensitivity.
Cancer:
A systematic review of unblinded clinical trials involving a total of 643 cancer patients using melatonin found a reduced incidence of death. Another clinical trial is due to be completed in 2012. Melatonin levels at night are reduced to 50% by exposure to a low-level incandescent bulb for only 39 minutes, and it has been shown that women with the brightest bedrooms have an increased risk for breast cancer. Reduced melatonin production has been proposed as a likely factor in the significantly higher cancer rates in night workers.
Gallbladder stones:
Melatonin presence in the gallbladder has many protective properties, such as converting cholesterol to bile, preventing oxidative stress, and increasing the mobility of gallstones from the gallbladder.[69] It also decreases the amount of cholesterol produced in the gallbladder by regulating the cholesterol that passes through the intestinal wall. In guinea pigs, melatonin administration restored normal function by reducing inflammation after induced Cholecystitis, whether administered before or after onset of inflammation.[69] Relatively speaking, concentration of melatonin in the bile is 2-3 times higher than the otherwise very low daytime melatonin levels in the blood across many diurnal mammals, including humans.
Other:
Melatonin is involved in the regulation of body weight, and may be helpful in treating obesity (especially when combined with calcium).
Histologically, it is believed that melatonin has some effects for sexual development in higher organisms.[72] It is involved in the seasonal timing of reproduction in rodents, at least.
Use as medication or dietary supplement:
The use of melatonin as a drug can entrain (synchronize) the circadian clock to environmental cycles and can have beneficial effects for treatment of certain forms of insomnia. Its therapeutic potential may be limited by its short biological half-life, poor bioavailability, and the fact that it has numerous non-specific actions.[73] In recent studies though, prolonged release melatonin has shown good results in treating insomnia in older adults.
The primary motivation for the use of melatonin may be as a natural aid to better sleep. Incidental benefits to health and well-being may accumulate, due to melatonin's role as an antioxidant and its stimulation of the immune system and several components of the endocrine system.
Dosage:
Studies from Massachusetts Institute of Technology have said that melatonin pills sold as supplements contain three to ten times the amount needed to produce the desirable physiologic nocturnal blood melatonin level for a more rapid sleep onset. Dosages are designed to raise melatonin levels for several hours to enhance quality of sleep, but some studies suggest that smaller doses (for example 0.3 mg as opposed to 3 mg) are just as effective. Large doses of melatonin can even be counterproductive: Lewy et al. provide support to the "idea that too much melatonin may spill over onto the wrong zone of the melatonin phase-response curve" (PRC). In one of their subjects, 0.5 mg of melatonin was effective while 20 mg was not.
Availability and safety of supplementation:
Melatonin is available without prescription in most cases in the United States and Canada, while it is available only by prescription or not at all in some other countries. The hormone may be administered orally, as capsules, tablets or liquid, via sublingual or buccal strips, or as transdermal patches.
Dietary supplement:
In the USA, because it is sold as a dietary supplement and not as a drug, the Food and Drug Administration (FDA) regulations that apply to medications are not applicable to melatonin. However, new FDA rules will, by June 2010, ensure that all production of dietary supplements must comply with "current good manufacturing practices" (cGMP), and be manufactured with "controls that result in a consistent product free of contamination, with accurate labeling. In addition, the industry has been required to report to the FDA "all serious dietary supplement related adverse events" and the FDA has, with the cGMP guidelines, recently begun enforcement of that requirement.
Prolonged release
Melatonin is available as a prolonged-release prescription drug, trade-name Circadin®, distributed by Neurim Pharmaceuticals. The European Medicines Agency (EMEA) has approved Circadin 2 mg (prolonged-release melatonin) as monotherapy for the short-term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.
Side effects
Melatonin appears to cause very few side effects in the short term, up to three months, when healthy people take it at low doses. A systematic review in 2006 looked specifically at efficacy and safety in two categories of melatonin usage: first, for sleep disturbances which are secondary to other diagnoses and, second, for sleep disorders such as jet lag and shift work which accompany sleep restriction. The combined results of the nine studies reviewed with regard to sleep onset latency in subjects with secondary sleep disorders favored melatonin over placebo, but not to a significant degree. However when one deviant study was excluded, melatonin was significantly better than placebo. Similar results were obtained regarding the shift work and jet lag groups. The seventeen randomised controlled trials with 651 participants showed no evidence of adverse effects of melatonin. The study concludes: "There is evidence that melatonin is safe with short term use." In most of their analyses they are able to state that there is no significant difference between melatonin and placebo; even the most common adverse events reported; headache, dizziness, nausea and drowsiness; did not significantly differ for melatonin vs. placebo. A similar analysis by the same team a year earlier on the efficacy and safety of exogenous melatonin in the management of primary sleep disorders found that: "There is some evidence to suggest that melatonin is effective in treating delayed sleep phase syndrome," and that evidence suggests that melatonin is safe with short-term use, three months or less.
Some unwanted effects in some people, especially at high doses (~3 mg/day or more) may include: headaches, nausea, next-day grogginess or irritability, hormone fluctuations, vivid dreams or nightmares and reduced blood flow.
While no large, long-term studies which might reveal side effects have been conducted, there do exist case reports about patients who have taken melatonin for years.
Melatonin can cause somnolence (drowsiness), and therefore caution should be shown when driving, operating machinery, etc.
In individuals with auto-immune disorders, there is concern that melatonin supplementation may ameliorate or exacerbate symptoms due to immunomodulation.
Individuals who experience orthostatic intolerance, a cardiovascular condition that results in reduced blood pressure and blood flow to the brain when a person stands, may experience a worsening of symptoms when taking melatonin supplements, a study at Penn State College of Medicine's Milton S. Hershey Medical Center suggests. Melatonin can exacerbate symptoms by reducing nerve activity in those who experience the condition, the study found. The use of melatonin derived from animal pineal tissue may carry the risk of contamination or the means of transmitting viral material. The synthetic form of this medication does not carry this risk.
Melatonin notes:
Melatonin or N-acetyl-5-methoxytryptamine is a hormone occurring naturally in animals and other living organisms like algae. Melatonin is highly essential to regulate the circadian rhythms of numerous biological functions. The biological effects of melatonin are achieved through the activation of melatonin receptors and some owing to its pervasive and powerful antioxidant property along with the protection of nuclear and mitochondrial DNA. Dietary supplements of melatonin are available in the United States since 1993. Trace amounts of melatonin can be derived from some food, though it cannot increase the plasma melatonin levels. Over-the-counter sales of the melatonin are banned in certain countries including Germany.
Melatonin is formed by pinealocytes in the pineal gland and by the retina, lens, GI tract and other tissues in humans and other higher animals. Pineal gland creates melatonin under the influence of the suprachiasmatic nuclei (SCN) of the hypothalamus. Skin is the largest organ in humans that biosynthesize melatonin along with its byproduct- AFMK. They are synthesized naturally from the amino acid tryptophan through the synthesis of serotonin that is converted to melatonin by the action of the enzymes N-acetyltransferase and 5-hydroxyindole-O-methyltransferase.
Melatonin is also formed by certain variety of peripheral cells like bone marrow cells, lymphocytes and epithelial cells in high concentration than the melatonin found in the blood. Melatonin is even manufactured by some plants, like rice wherein the ingested form of melatonin is provided with the capability to reach and bind to melatonin binding sites in the brains of mammals.
Melatonin acts as synchronizer of the biological clock by controlling circadian rhythm in the humans. Thus it is used for the treatment of circadian rhythm disorders. It also acts as a powerful antioxidant in human. The users of melatonin are reported with certain cases of increase in vivid dreaming. People suffering from autism spectrum disorders have low levels of this hormone in their body.
News: Melatonin can extend youth - says researchers.
Researchers from Laboratoire Arago in Banyuls sur Mer (CNRS / Université Pierre et Marie Curie) have found that melatonin has antiaging effect as it delays the signs of aging in C. russula. Melatonin is a ‘time-keeping' hormone which is naturally secreted by the body during the night allowing an organism to synchronize with the day/night rhythm. It is an antioxidant, an anti-depressant and helps to remediate sleep problems.
The age related changes in sleep wake pattern has been suggested due to changes in the suprachiasmatic nucleus(SCN) of the hypothalamus which is master circadian pacemaker, the activity of which is synchronized by the photoperiodic information of day and night perceived through the eyes. SCN affects pineal gland and induces the nocturnal production of melatonin tjere by changing feed back action of SCN with aging. Until now, studies were based on short-term acute melatonin administration and it remained unclear if the anti-aging effect of melatonin on the time keeping system is due to its rhythmic production or its production.
In the experiment, the effect of a long term continuous melatonin delivery through subcutaneous implants on adult shrews was investigated. The daily activity rhythms was monitored from before first clues of senescence till death for a period of more than 500 days. The appearance of these first aging signs was delayed significantly by at least 3 months. The rhythmic activity pattern was maintained for an additional year when compared to controls.
Melatonin may redeem visibility in inflammatory diseases:
The report published in American Journal of Pathology presented by Sande ET regarding remedial effect of melatonin had revealed that melatonin may play an important role in curing uveitis which is a commonly diagnosed malady eye ailment.
Patients who are diagnosed with uveitis acquire immediate puffiness, reddish color and severe pain around their eyes. In the due process the visibility also decreases. Cases have reported that if not paid proper heed, uveitis can damage eyesight completely. Recent studies have reportedly shown an increase of 10 to 15 percent of occurrence of complete loss of vision in the United States of America. Various reasons can be attributed responsible for uveitis which includes injury to an eye, contamination, arthritis and above all non- curable ailments. Presently no concrete cure has been found out to treat uveitis; however numerous drugs can be used on a temporary basis for example Corticoid stiffer (eye drop). Prolonged use is however not advisable as it leads to pessimistic results including damage of optic nerve which can cause irreversible loss of vision.
Experts working at the University of Buenos Aires and also the team of the National Research Council (CONICET) concluded that melatonin which manages sleep patterns including decrease in jet lag can be a fruitful remedy to restrict the ophthalmic burning sensation in uveitis. Analyst discovered dual reasons for this inflammation through a research model of uveitis. Melatonin did act as a savior and diminished the visibility of medical symptoms of uveitis to a great extent i.e. expansion of the blood vessels, cataract and inflammation.
Based on the report and the information accumulated, melatonin has proven its worth in treating and curing uveitis to a desired length in spite of its inadequacy in harmful parallel effect at high dose. Melatonin combined with cortico steroid mechanism also works for those patients who are diagnosed with chronic uveitis and thereby deteriorates the pace and complexity which erupts due to cortico steroid. Researches in pipeline may focus on how melatonin can be shield for an eye to protect itself from inflammatory diseases.
|
|
Drug category:hypnotic
 Melatonin
Buy here
|
|
My Basket